News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Reuters Videos110d agoneutralVIDEO
Novo sues Lilly, claiming misleading ads in weight-loss drug battleStocktwits110d agobearish
Novo Nordisk Lawsuit Against Eli Lilly: Wegovy Maker Alleges Misleading Zepbound, Mounjaro AdsThe Wall Street Journal110d agoneutral
Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli LillyThe Wall Street Journal110d agoneutral
Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli LillyReuters110d agoneutral
Novo Nordisk says it is suing Eli Lilly, accusing it of false advertisingFinancial Times110d agoneutral
Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss fightGuruFocus.com111d agoneutral
Scribe Therapeutics Files $107.2 Million IPO as Sanofi Backs Share PurchaseBloomberg111d agoneutral
‘Wild West’ of Untested Peptides Has Americans Paying in Crypto to Get Their FixSimply Wall St.113d agoneutral
Eli Lilly (LLY) Stock Looks Undervalued On Fair Value Yet Full On EarningsInvestor's Business Daily114d agobullish
IPO Stock Of The Week: This Eli Lilly Partner Soars 118% In Three MonthsInsider Monkey115d agobullish
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli LillyThe Wall Street Journal115d agobullish
Eli Lilly to Buy Psychedelic Firm AtaiBeckley for Initial $2.8 BillionThe Wall Street Journal115d agobullish
🔎 Under the Radar: AtaiBeckley Stock Soars on Eli Lilly Deal